tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN

Compare Basilea Pharmaceutica (BSLN) vs. Competitors

Compare
7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Basilea Pharmaceutica
CHF52.60
CHF627.42M
16.63
8.43%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF135.26M
-2.50
-4.42%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.15
CHF804.52M
-8.17
195.50%
2 Buy
0 Hold
0 Sell
Moderate Buy
Kuros Biosciences
CHF28.16
CHF944.22M
498.59
23.84%
1 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF15.00
CHF311.39M
-487.07
78.36%
1 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF14.84
CHF208.26M
-0.98
-0.80%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:BSLN
Basilea Pharmaceutica
52.10
5.10
10.85%
CH:MOLN
Molecular Partners AG
3.35
0.11
3.40%
CH:IDIA
Idorsia Ltd
3.15
2.06
187.93%
CH:KURN
Kuros Biosciences
24.10
5.40
28.88%
CH:NWRN
Newron Pharmaceuticals SpA
15.00
6.64
79.43%
CH:SANN
Santhera Pharmaceuticals Holding
14.84
-0.36
-2.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts